This company has been acquired
このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
DICE Therapeutics 配当金
配当金 基準チェック /06
DICE Therapeutics does not have a record of paying a dividend.
主要情報
n/a
配当利回り
n/a
配当性向
| 業界平均利回り | 2.2% |
| 次回配当支払日 | n/a |
| 配当落ち日 | n/a |
| 一株当たり配当金 | n/a |
| 一株当たり利益 | -US$2.18 |
| 3年後の配当利回り予想 | 0% |
最近の配当金アップデート
更新なし
Recent updates
We're Not Very Worried About DICE Therapeutics' (NASDAQ:DICE) Cash Burn Rate
May 14
DICE Therapeutics positive phase 1 data for psoriasis candidate leads shares 71% higher
Oct 11Here's Why We're Not Too Worried About DICE Therapeutics' (NASDAQ:DICE) Cash Burn Situation
Sep 11DICE Therapeutics GAAP EPS of -$0.58
Aug 11DICE Therapeutics initiated at buy at Wainwright on platform for small molecule drugs
Jul 18決済の安定と成長
配当データの取得
安定した配当: Insufficient data to determine if DICE's dividends per share have been stable in the past.
増加する配当: Insufficient data to determine if DICE's dividend payments have been increasing.
配当利回り対市場
| DICE Therapeutics 配当利回り対市場 |
|---|
| セグメント | 配当利回り |
|---|---|
| 会社 (DICE) | n/a |
| 市場下位25% (US) | 1.5% |
| 市場トップ25% (US) | 4.7% |
| 業界平均 (Pharmaceuticals) | 2.2% |
| 3年後のアナリスト予想 (DICE) | 0% |
注目すべき配当: Unable to evaluate DICE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
高配当: Unable to evaluate DICE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
株主への利益配当
収益カバレッジ: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
株主配当金
キャッシュフローカバレッジ: Unable to calculate sustainability of dividends as DICE has not reported any payouts.